Pharmacy Podcast Network

Marley Medicure Manifesto to Dismantle the Traditional PBMs | Pharmacy Podcast Nation

"The only way to change the status-quo is to get off your ass and change it." 
Dave Marley, Marley Drug: 
It's not easy but it's possible to fight the 3 largest PBMs in your local community with your pharmacy services. Listen into this podcast & share with other pharmacy owners for several ideas on beating the PBMs in Community Pharmacy. 
Thank you ApproRx & P.U.T.T. for sponsoring this podcast webinar.  
Here's the back-drop information on Marley Drug & Medicure: 
https://www.medicure.com/about 
Work with Medicure today: 
Neal Owens nowens@medicure.com 
IN A RARE MOVE, A DRUG MANUFACTURER WILL BYPASS THE TRADITIONAL APPROACH AND PROVIDE ACCESS TO AFFORDABLE MEDICATIONS ACROSS THE UNITED STATES VIA MARLEY DRUG’S ESTABLISHED MAIL ORDER PHARMACY.  
With licensing to deliver prescription drugs to all 50 states, Washington D.C. and Puerto Rico, and with an established vision to deliver low cost generic medications, Marley Drug Pharmacy was the natural choice for like-minded Canadian drug manufacturer, Medicure Inc., to further expand distribution of its products within the United States, included its branded statin, Zypitamag® (pitavastatin).  
The acquisition allows Medicureto bypass wholesalers and pharmacy benefit managers (PBMs), in an effort to reduce consumer drug costs and provide patients across the U.S. easier access to Zypitamag®, which was extremely difficult for patients and physicians to access because of restrictions and high co-pays dictated by insurers and PBMs. Through Marley Drug Pharmacy, Medicurecan now deliver Zypitamag® to patients in every U.S. state without customers needing to use their insurance, or worry if the prescription will be covered. Medicurecan also provide Zypitamag® at a lower price overall, and a fraction of the cash price of a leading branded statin Livalo® (pitavastatin). As a manufacturer, Medicureintends to provide other branded medications using a similar approach, in addition to extremely low cost generic medications.
“It’s a perfect and responsible transition for Marley Drug,” said Dr. David Marley, CEO & President of Marley Drug. “Medicureshares our moral mission to cut drug costs for consumers. Since 2012 we have offered Marley’s Extended Supply Generic Drug Program, which was designed to battle the skyrocketing costs of name-brand drugs, and offer patients affordable alternatives, without increasing co-pays or limiting access to popular generics.  We worked hard to acquire permits in every state.  Now Medicurecan offer Zypitamag® from coast to coast at a fraction of the cost, without the hassle of PBMs and wholesalers.” 
“Medicure and Marley Drug have the same vision. We want to deliver safe, efficacious and cost-effective medicines that benefit patients and healthcare providers. Our goal is to increase patient access to Zypitamag® while keeping the process and pricing as simple as possible. Through Marley Drug Pharmacy, we can now provide these benefits regardless of insurance or location,” said Dr. Albert Friesen, CEO of Medicure. “There will be no changes to the hours, location or to the great staff and customer service that Marley has built, and look to hire more staff as business grows. Dave Marley will remain a member of the leadership team, and we want Marley Drug to remain a trusted business within the community, and hopefully, this is a game-changing approach that gains attention nationwide.”
Thanks RxSafe for Sponsoring this episode: 
RxSafe.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Focus Collab | Lets Pharmonize

In this episode we are joined by a very special guest, Jill Murphy from Pharmacy Focus Podcast, to discuss some old-timey medical treatments and how they've evolved over time. From the Iron Lung to the Clap, we hope you enjoy these four antiquated medical treatments.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane, Cal and Jill are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Opioid Madness Part Two | PAIN POD

March Madness inspired us, and our audience has waited long enough. What better time, than during a pandemic, to dive into “OPIOID MADNESS” and crown “The Greatest Opioid of All Time”!!!
In this episode of the “PAIN POD”, Mark “Pain Guy” Garofoli will continue the conversation from Opioid Madness Part 1, the opioid bracketology, or perhaps an “Opioidology”, but definitely a whole bunch of “Opioid Madness”. The battle of poppy versus poppy, and of course a bunch of man-made opioid opponents as well. Cool names and fancy formulations only get one so far, and we simply have no room for bias, thus pharmacology will rule as law of the land, to ultimately crown, “THE GREATEST OPIOID OF ALL TIME”.
The blood thirsty, constipating, yet definitely not sedating championship opioid brawl continues. One opioid, an opioid of all opioids, will remain standing atop the mountain of Mu, declaring its victory over all other opioids from all lands near and far. Which opioid will it be? The PAIN POD crowns the champ!
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

You Never Give Me Your Money | GameChangers

Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money.
Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432
Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195
CPE details for GameChangers Podcast April 2021
Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis.
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

APhA President Sandra Leal, PharmD | Locked On Pharmacy

Episode 21: Sandra Leal
Sandra Leal, the 166th president of the American Pharmacists Association, was powerfully influenced by her childhood experiences growing up in an Arizona border town – including the pharmacist in nearby Mexico who essentially served as her family’s main health care provider.
In this episode, we talk about those formative experiences, and discuss the twin issues dominating pharmacy today: the pandemic, and structural racism in pharmacy. Recorded April 2, 2021.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Unique Partnerships in Pharmacy - Why Paramedicine Could Help Access to Care for the Underserved and Advance Public Health Initiatives | Public Healt...

Dr. Victoria Reinhartz PharmD is an Assistant Professor of Pharmacy Practice at LECOM School of Pharmacy and the Founder & CEO of Mobile Health Consultants, Inc. She also serves as the Consultant Pharmacist for the Manatee County Community Paramedicine Program in Bradenton, FL. Within this role, Dr. Reinhartz and her team resolve medication issues or disease factors which are contributing to frequent 911 use, ER visits, or hospitalization.
Dr. Reinhartz's clinical impact has been recognized with a Chief’s Commendation Award and a Congressional EMS Unit Citation Award for exceptional care provision and leadership within EMS. Dr. Reinhartz has also garnered national attention from the United States Public Health Service for collaborative innovation improving community health outcomes. Most recently, she was named the 2020 Next-Generation Pharmacist Civic Leader, for implementing a vision of interprofessional care that spotlights the needs of underserved communities. She is an advocate of Mobile Integrated Health, Community Paramedicine, and interprofessional collaboration with Emergency Medical Services. 
What public health means to Dr. Reinhartz is embracing interprofessional skillsets to improve access to care, health outcomes, and quality of life for our communities.
Social Media LinkedIn - https://www.linkedin.com/in/victoriareinhartz/
Links Next Generation Pharmacist Awards 2020https://nextgenpharmacist.com/pharmacy-times-and-parata-systems-announce-the-2020-next-generation-pharmacist-winners/ 
Collaboration by emergency medicine pharmacists and prehospital services providers - American Journal of Health-System Pharmacy, Volume 77, Issue 12, 15 June 2020, Pages 918–921
https://academic.oup.com/ajhp/article-abstract/77/12/918/5831519 
EMS World Expo Quick Take: How pharmacists improve EMS patient care - A pharmacist can help EMS improve patient outcomes, participate in protocol development, and collaborate on EMS research projects (Nov 2018) - https://www.ems1.com/pharmacology/articles/ems-world-expo-quick-take-how-pharmacists-improve-ems-patient-care-ZcojQQ56JiCN5GfY/
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A Story of Innovation in Health System Pharmacy (02) | Allegheny Health Network

Chapter 2 of 3 
Featuring: Allegheny Health Network Pharmacy Services 
Medication Safety
Technology
Pharmacist/ Technician roles
Education and training
Guests:
Laura (McCoy) Mark, PharmD - Vice President, Pharmacy
Kimberly (Miller) Mehta, PharmD, MPH, MHA - Pharmacy Director of Medication Safety and Regulatory 
Rich Kaplan, PharmD 
This podcast series is sponsored by Omnicell. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19 Vaccine Alleged Infertility | Lets Pharmonize

In this episode, we are joined by Dr. Jordan Smith, Assistant Professor of Clinical Sciences at High Point University and our go-to expert for questions on infectious diseases. We'll discuss the rumors of infertility associated with the mRNA COVID-19 vaccine, and any possible long-term effects of getting vaccinated. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music by FesliyanStudiosAll Rights Reserved
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Express Scripts Fails to Defeat Louisiana Prescription Fee Suit | PBM Reform Podcast Series

LIPA v ESI: Fight for the Right to Be Paid 
What happens when a state implements provider fee statutes that are officially approved by CMS but one of the big 3 PBMs still claims exemption?
Join guest host Monique Whitney with special guests Randal Johnson, JR Whaley, and MJ Terrebonne as they discuss Louisiana's legal battle with ESI over 10 cents per claim, and the ramifications this could have on state Medicaid programs nationwide.
Host: 
Monique Whitney, Executive Director, Pharmacists United for Truth & Transparency 
Guests:  
Randal Johnson, CEO, Louisiana Independent Pharmacies Association 
JR Whaley, Legal Counsel, Louisiana Independent Pharmacies Association 
MJ Terrebonne, Health Policy Expert & retired Director of Pharmacy, Louisiana Medicaid
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Dynamics of 340B Program Spotlight the Value of Strong Pharmacy-Finance Partnerships | Future of Pharmacy Podcast

Learn how health systems can leverage a vibrant, pharmacy-finance partnership to drive successful 340B programs, and allow pharmacy staff more time to focus on patient care. Find out why 340B program management has evolved, the program challenges that health systems still face, and the data and operational complexities that necessitate a cross-functional approach.
Guests:                     
Eric Iorfido, PharmD, 340B Program Manager, Penn Highlands DuBois, PA
Charles Hirner, RPh, Senior Director, Omnicell 340B Operations
Host:                         
Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Tennessee Senator Shane Reeves | PBM Reform Podcast Series

Tennessee Gov. Bill Lee signed HB 786, a comprehensive PBM reform bill that strengthens existing fair pharmacy audit laws, limits PBM adjudication fees, and prohibits a PBM from reimbursing a pharmacy less than it reimburses a PBM-affiliated pharmacy.May 30, 2019
Tennessee SB650
Present law defines "pharmacy benefits manager" (PBM) to mean a person, business, or other entity and any wholly or partially owned subsidiary of the entity, that administers the medication and/or device portion of pharmacy benefits coverage provided by a health insurance plan, subject to certain exceptions.
Present law provides detailed requirements for the conduct of an audit of records of a pharmacist or pharmacy by a health insurance plan, a PBM, the state or its political subdivisions, or any other entity representing the same. One such audit requirement is that a clerical or recordkeeping error regarding a required document or record may not, in and of itself, constitute fraud; however, the claims may be subject to recoupment. This bill instead provides that a clerical or recordkeeping error identified during an audit is not prima facie evidence of fraud or intentional misrepresentation and must not be the basis of a recoupment unless the error results in an actual overpayment to the pharmacy or the wrong medication being dispensed to the patient. As under present law, a clerical error will not be subject to criminal penalties without proof of intent to commit fraud. 
Shane Reeves is an American businessman, pharmacist and politician who is the State Senator for the 14th District of Tennessee, which is composed of Bedford County, Moore County, Lincoln County, Marshall County, and part of Rutherford County. As a seventh-generation Tennessean, Senator Shane Reeves has spent his life raising a family and opening businesses in middle Tennessee. He understands the importance of family, character, and conservative values to the people in this community.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Good the Bad & the Ugly | GameChangers

More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.
This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.
Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345
Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download 
CPE details for GameChangers Podcast April 2021
Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Flip the Pharmacy: 1 Year Later | Beyond the Sig

In March of 2020, we launched Beyond the Sig by hosting Randy McDonough, Director of Practice Transformation of Flip the Pharmacy, to discuss how the Flip the Pharmacy initiative was supporting pharmacies in practice transformation.  
During this episode of Beyond the Sig, PPCN Executive Director Stephanie McGrath sits down with Randy virtually to reflect on the past year, how Flip the Pharmacy has supported pharmacies through the COVID-19 pandemic, and highlight some of the brightest innovations demonstrated by participating pharmacies.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

NCPA 2020 Lifetime Achievement Award | Pharmacy Crossroads

Nasir Mahmood is a remarkable pharmacy owner.  Indeed, so remarkable that the NCPA named him the winner of the 2020 Lifetime Achievement Award.  And the list of honors and service he has provided to the profession and to his community justifies this high honor.
In this podcast Nasir and his son, Rehan, Mahmood share with Kneeland the PharmacyCrossRoads listeners several of the personal philosophy and business practices that allow Pine Plains Pharmacy, in Pine Plains, New York to be such an important part of this small community halfway between New York City and Albany, NY. 
Nasir, who also earned an MBA shared his view that knowing people, calling them by name and finding ways for the pharmacy to stock the special or unique items they want is one critical success factor.  While the pharmacy is small, just under 2000 sq. feet, he says they find ways to fit items into the pharmacy.  Adding to that idea is a robust special-order program where he says find his willingness to orders items an important customer service. 
Rehan tells how he worked with suppliers, the city’s fire department and created an appointment system that allowed them to provide this small town with a successful, and ongoing, COVID vaccination program. 
One heartfelt aspect of Nasir’s philosophy is giving back, thus he has served President and Chairman of the Pharmacist Society of the State of New York, winner of the Bowl of Hygiea Award, serves on the State Board of Pharmacy and is active in both NCPA and APhA. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Arrested Development, Cannabis & Adolescents | CRx Podcast

Arrested Development 
https://www.crxmag.com/issues/2021/winter/arrested-development.shtml
The related research letter published in JAMA Psychiatry on 3/27/2019 titled; Association of Prenatal Cannabis Exposure With Psychosis Proneness Among Children in the Adolescent Brain Cognitive Development (ABCD) Study. 
Jeremy Fine is entering medical school this fall was a key contributor behind the creation of this research letter. 
Association of Prenatal Cannabis Exposure With Psychosis Proneness Among Children in the Adolescent Brain Cognitive Development (ABCD) Study
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2729440
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Zolgensma, The Most Expensive Drug Ever | Lets Pharmonize

Description: Viagra, Crestor, Eliquis, and many other brand-name medications come to mind when the discussion turns to expensive drugs. These drugs are pocket change in comparison to Zolgensma, a new(ish) gene therapy for Spinal Muscular Atrophy that costs as much as a private island. Tune in as our hosts discuss this incredible drug and some of the ramifications of its incredible price tag.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music by FesliyanStudios
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Demonstrating Value Through A Patient Care Program | Beyond the Sig

On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Eric Yarnell, Vice President of Pharmacy at Gateway Health. He brings both pharmacist and payer perspectives as a member of the Flip the Pharmacy Payer Advisory Board. In this conversation, Eric shares how Gateway Health has worked with a community pharmacy network to implement a patient care program and how community pharmacy enhanced services bring value to health plans.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Not All Heroes Wear Capes | Beyond the Sig

Skippack Pharmacy has been leading mass COVID-19 vaccination efforts in the Schwenksville, Pennsylvania community and their efforts have gained national attention. You might recognize Skippack’s owner as the Superman pharmacist recently featured on Good Morning America. Today, we will hear from two members of the Skippack team, who have been working behind the scenes to help Skippack Pharmacy administer over 10,000 COVID-19 vaccines.
On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Skippack Pharmacy intern, Erica Mabry, and American Pharmacists Association (APhA) Chief of Governance & State Affiliates and Executive Director of the APhA Foundation, Mitch Rotholz, who is the policy lead for immunizations for the profession. They share their experiences working together to coordinate these clinics and their perspectives on the future of community pharmacy practice transformation.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A Story of Innovation in Health System Pharmacy (01) | Allegheny Health Network

Chapter 1 of 3 
Featuring: Allegheny Health Network Pharmacy Services 
AHN overview and history
AHN Pharmacy Transformation – Patient – centered care planning
Becoming one team
Standardized practice / technology throughout all sites
Guests:
Laura (McCoy) Mark, PharmD - Vice President, Pharmacy
Arpit Mehta, Pharm.D., MPH, MHA - Director of Pharmacy
Kelley Wasicek, BS Pharm Director of Pharmacy
Rob Simpson, PharmD 
This podcast series is sponsored by Omnicell. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Cannabis Industry Election Victories | CRx Podcast

The cannabis industry won at the ballot box in the recent election, with four states passing laws to make cannabis legal for adults and two approving cannabis for medical purposes. These results moved the National Cannabis Industry Association (NCIA) closer to its goal of building a robust cannabis industry while supporting state laws and advocating for federal policy reforms.   
On November 3, 2020, voters in five states made a definitive statement about cannabis use. Arizona, Montana, New Jersey, and South Dakota approved adult use of cannabis. South Dakota also approved a medical initiative, along with Mississippi, which approved comprehensive cannabis medical options.  
The National Cannabis Industry Association (NCIA) has been working toward outcomes such as these since 2010. With 2,000 members nationwide, the organization is supporting the industry as cannabis becomes a thriving business and a real economic force. In recent years, NCIA has been a vocal advocate for social equity, working to promote expungement of criminal records of many people—largely from minority communities—who were unfairly incarcerated as part of the ill-conceived War on Drugs.
The results of the initiatives in these five states illustrate how far the industry has come. The people have spoken, and their voice was definitive.
“The margins were higher than we expected,” says Morgan Fox, spokesperson for NCIA. “In Arizona, there was a 60% margin, while the margin in New Jersey was 66%, 10 points higher than it was in California when it passed an adult use initiative in 2016. These results are not just political victories; they will likely have widespread ramifications. Importantly, it will be much more difficult for law enforcement to use cannabis as a weapon against minority populations. Instead, we will likely see more economic opportunities in the industry and fewer arrests overall.”
Although there were differences among the measures passed, those that supported legalization all set 21 as the legal age for use. In New Jersey, the law requires that the state set a regulatory structure, along with limits for possession and homegrown cannabis plants. Arizona established the number of plants allowed at six, while South Dakota limited cultivation to three. The law in Arizona also stated that the Department of Health Services must promote business ownership and industry participation among people from communities who have been harmed by former cannabis policies. Furthermore, a portion of cannabis tax revenue will be set aside for the newly created Justice Reinvestment Fund.    
To date, almost 34% of Americans live in states with laws establishing cannabis as legal and regulated for adults. Four of the five states that recently passed laws legalizing cannabis have been responsible for roughly 60,000 cannabis arrests each year, mostly for simple possession. On the economic side, researchers estimate that the combined value of the cannabis markets in these five states will climb to more than $3.1 billion by 2025. In states where cannabis is now legal, Congressional representation will increase by 29 representatives and eight senators.
In sum, cannabis is now legal for adults in 15 states, as well as the District of Columbia and the territories of CNMI and Guam. What’s more, 36 states and several territories have comprehensive medical cannabis laws. Cannabis is now legal in some form in 47 states in the United States.
Guests: 
David L. Nathan, MD, DFAPA
President, Board of Directors
Doctors for Cannabis Regulation
Abby Stoddard, PharmD, MBA 
The Client Centered Network
www.clientcn.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices